<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Okuno S</submitter><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Society for the Promotion of Science</funding><pagination>21397</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10696029</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Although an increased risk of myocarditis has been observed after vaccination with mRNA encoding severe acute respiratory syndrome coronavirus 2 spike protein, its underlying mechanism has not been elucidated. This study investigated the direct effects of spike receptor-binding domain (S-RBD) on human cardiomyocytes differentiated from induced pluripotent stem cells (iPSC-CMs). Immunostaining experiments using ACE2 wild-type (WT) and knockout (KO) iPSC-CMs treated with purified S-RBD demonstrated that S-RBD was bound to ACE2 and internalized into the subcellular space in the iPSC-CMs, depending on ACE2. Immunostaining combined with live cell imaging using a recombinant S-RBD fused to the superfolder GFP (S-RBD-sfGFP) demonstrated that S-RBD was bound to the cell membrane, co-localized with RAB5A, and then delivered from the endosomes to the lysosomes in iPSC-CMs. Quantitative PCR array analysis followed by single cell RNA sequence analysis clarified that S-RBD-sfGFP treatment significantly upregulated the NF-kβ pathway-related gene (CXCL1) in the differentiated non-cardiomyocytes, while upregulated interferon (IFN)-responsive genes (IFI6, ISG15, and IFITM3) in the matured cardiomyocytes. S-RBD-sfGFP treatment promoted protein ISGylation, an ISG15-mediated post-translational modification in ACE2-WT-iPSC-CMs, which was suppressed in ACE2-KO-iPSC-CMs. Our experimental study demonstrates that S-RBD is internalized through the endolysosomal pathway, which upregulates IFN-responsive genes and promotes ISGylation in the iPSC-CMs.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes.</pubmed_title><pmcid>PMC10696029</pmcid><funding_grant_id>23K15128</funding_grant_id><funding_grant_id>21H02915</funding_grant_id><funding_grant_id>21bm0804008h0005</funding_grant_id><funding_grant_id>22bm0804035h0001</funding_grant_id><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Higo S</pubmed_authors><pubmed_authors>Okuno S</pubmed_authors><pubmed_authors>Tabata T</pubmed_authors><pubmed_authors>Ishino S</pubmed_authors><pubmed_authors>Sakata Y</pubmed_authors><pubmed_authors>Kameda S</pubmed_authors><pubmed_authors>Inoue H</pubmed_authors><pubmed_authors>Shiba M</pubmed_authors><pubmed_authors>Kondo T</pubmed_authors><pubmed_authors>Morishita Y</pubmed_authors><pubmed_authors>Ogawa S</pubmed_authors><pubmed_authors>Honda T</pubmed_authors><pubmed_authors>Miyagawa S</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes.</name><description>Although an increased risk of myocarditis has been observed after vaccination with mRNA encoding severe acute respiratory syndrome coronavirus 2 spike protein, its underlying mechanism has not been elucidated. This study investigated the direct effects of spike receptor-binding domain (S-RBD) on human cardiomyocytes differentiated from induced pluripotent stem cells (iPSC-CMs). Immunostaining experiments using ACE2 wild-type (WT) and knockout (KO) iPSC-CMs treated with purified S-RBD demonstrated that S-RBD was bound to ACE2 and internalized into the subcellular space in the iPSC-CMs, depending on ACE2. Immunostaining combined with live cell imaging using a recombinant S-RBD fused to the superfolder GFP (S-RBD-sfGFP) demonstrated that S-RBD was bound to the cell membrane, co-localized with RAB5A, and then delivered from the endosomes to the lysosomes in iPSC-CMs. Quantitative PCR array analysis followed by single cell RNA sequence analysis clarified that S-RBD-sfGFP treatment significantly upregulated the NF-kβ pathway-related gene (CXCL1) in the differentiated non-cardiomyocytes, while upregulated interferon (IFN)-responsive genes (IFI6, ISG15, and IFITM3) in the matured cardiomyocytes. S-RBD-sfGFP treatment promoted protein ISGylation, an ISG15-mediated post-translational modification in ACE2-WT-iPSC-CMs, which was suppressed in ACE2-KO-iPSC-CMs. Our experimental study demonstrates that S-RBD is internalized through the endolysosomal pathway, which upregulates IFN-responsive genes and promotes ISGylation in the iPSC-CMs.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-22T08:07:08.089Z</modification><creation>2025-04-05T22:24:08.033Z</creation></dates><accession>S-EPMC10696029</accession><cross_references><pubmed>38049441</pubmed><doi>10.1038/s41598-023-48084-7</doi></cross_references></HashMap>